Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Sees Significant Growth in Short Interest

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) saw a large growth in short interest during the month of August. As of August 14th, there was short interest totaling 23,657 shares, a growth of 1,351.3% from the July 30th total of 1,630 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.

Institutional Trading of Towa Pharmaceutical

An institutional investor recently bought a new position in Towa Pharmaceutical stock. Public Employees Retirement System of Ohio bought a new stake in shares of Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) during the 2nd quarter, according to its most recent filing with the SEC. The fund bought 96,968 shares of the company’s stock, valued at approximately $3,285,000.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley raised shares of Towa Pharmaceutical to an “overweight” rating in a research report on Friday, June 12th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy”.

Towa Pharmaceutical Stock Performance

TWAPF opened at $25.98 on Thursday. Towa Pharmaceutical has a fifty-two week low of $25.71 and a fifty-two week high of $26.00. The firm’s fifty day moving average price is $25.82 and its two-hundred day moving average price is $25.50.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.